Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana
- PMID: 22134146
- PMCID: PMC3884088
- DOI: 10.1097/QAI.0b013e3182426227
Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana
Abstract
Background: Cervical cancer is a major public health problem in resource-limited settings, particularly among HIV-infected women. Given the challenges of cytology-based approaches, the efficiency of new screening programs need to be assessed.
Setting: Community and hospital-based clinics in Gaborone, Botswana.
Objective: To determine the feasibility and efficiency of the "see and treat" approach using visual inspection acetic acid (VIA) and enhanced digital imaging (EDI) for cervical cancer prevention in HIV-infected women.
Methods: A 2-tier community-based cervical cancer prevention program was implemented. HIV-infected women were screened by nurses at the community using the VIA/EDI approach. Low-grade lesions were treated with cryotherapy on the same visit. Women with complex lesions were referred to our second tier specialized clinic for evaluation. Weekly quality control assessments were performed by a specialist in collaboration with the nurses on all pictures taken.
Results: From March 2009 through January 2011, 2175 patients were screened for cervical cancer at our community-based clinic. Two hundred fifty-three patients (11.6%) were found to have low-grade lesions and received same-day cryotherapy. One thousand three hundred forty-seven (61.9%) women were considered to have a normal examination, and 575 (27.3%) were referred for further evaluation and treatment. Of the 1347 women initially considered to have normal exams, 267 (19.8%) were recalled based on weekly quality control assessments. Two hundred ten (78.6%) of the 267 recalled women, and 499 (86.8%) of the 575 referred women were seen at the referral clinic. Of these 709 women, 506 (71.4%) required additional treatment. Overall, 264 cervical intraepithelial neoplasia stage 2 or 3 were identified and treated, and 6 microinvasive cancers identified were referred for further management.
Conclusions: Our "see and treat" cervical cancer prevention program using the VIA/EDI approach is a feasible, high-output and high-efficiency program, worthy of considering as an additional cervical cancer screening method in Botswana, especially for women with limited access to the current cytology-based screening services.
Figures
Similar articles
-
Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia.PLoS One. 2015 Apr 17;10(4):e0122169. doi: 10.1371/journal.pone.0122169. eCollection 2015. PLoS One. 2015. PMID: 25885821 Free PMC article.
-
Early experiences in integrating cervical cancer screening and treatment into HIV services in Zomba Central Hospital, Malawi.Malawi Med J. 2018 Sep;30(3):211-214. doi: 10.4314/mmj.v30i3.14. Malawi Med J. 2018. PMID: 30627358 Free PMC article.
-
Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field.Gynecol Oncol. 2008 Sep;110(3):402-7. doi: 10.1016/j.ygyno.2008.04.031. Epub 2008 Jun 16. Gynecol Oncol. 2008. PMID: 18556050 Free PMC article.
-
Cervical cancer screening in high- and low-resource countries: implications and new developments.Obstet Gynecol Surv. 2012 Oct;67(10):658-67. doi: 10.1097/OGX.0b013e3182732375. Obstet Gynecol Surv. 2012. PMID: 23112073 Review.
-
Lower genital tract neoplasia in women with HIV infection.Oncology (Williston Park). 1998 Dec;12(12):1735-9; discussion 1742, 1745, 1747. Oncology (Williston Park). 1998. PMID: 9874847 Review.
Cited by
-
Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective.BMC Womens Health. 2016 Jun 4;16:29. doi: 10.1186/s12905-016-0306-6. BMC Womens Health. 2016. PMID: 27259656 Free PMC article.
-
Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.BJOG. 2021 Nov;128(12):1986-1996. doi: 10.1111/1471-0528.16758. Epub 2021 Jun 14. BJOG. 2021. PMID: 34008294 Free PMC article.
-
Factors Related to Advanced Stage of Cancer Presentation in Botswana.J Glob Oncol. 2018 Dec;4:1-9. doi: 10.1200/JGO.18.00129. J Glob Oncol. 2018. PMID: 30532993 Free PMC article.
-
Clinical and sociodemographic factors associated with late stage cervical cancer diagnosis in Botswana.BMC Womens Health. 2021 Jul 6;21(1):267. doi: 10.1186/s12905-021-01402-5. BMC Womens Health. 2021. PMID: 34229672 Free PMC article.
-
Cost-effectiveness of cervical cancer screening and preventative cryotherapy at an HIV treatment clinic in Kenya.Cost Eff Resour Alloc. 2017 Jul 14;15:13. doi: 10.1186/s12962-017-0075-6. eCollection 2017. Cost Eff Resour Alloc. 2017. PMID: 28725164 Free PMC article.
References
-
- Report of a WHO consultation. World Health Organization; Geneva: 2002. Cervical cancer screening in developing countries.
-
- World Health Organization. Geneva: 2005.
-
- Hawes SE, Critchlow CW, Faye Niang MA, et al. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis. 2003 Aug 15;188(4):555–563. - PubMed
-
- Firnhaber C, Evans D, Friedman-Khalili R, et al. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana. J Clin Virol. 2011 Nov;52(3):265–268. - PubMed
-
- Arbyn M, Sankaranarayanan R, Muwonge R, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer. 2008 Jul 1;123(1):153–160. - PubMed